Loading clinical trials...
Loading clinical trials...
PHenotype-based RApid SEquencing of Guideline-directed Medical Therapy for Heart Failure With Reduced Ejection Fraction (PHRASE-HF): A Multicentre, Prospective, Non-interventional Study to Examine Outcomes of Rapid In-hospital Implementation of GDMT and Its Translation From Discharge Into Routine Care
Conditions
Locations
6
Germany
Research Site
Berlin, Germany
Research Site
Erfurt, Germany
Research Site
Gifhorn, Germany
Research Site
Leipzig, Germany
Research Site
Schwerin, Germany
Research Site
Wuppertal, Germany
Start Date
November 15, 2024
Primary Completion Date
June 30, 2027
Completion Date
June 30, 2027
Last Updated
April 3, 2026
NCT07083011
NCT07550790
NCT07037459
NCT05365282
NCT07547098
NCT06863155
AstraZeneca Clinical Study Information Center
CONTACT
1-877-240-9479information.center@astrazeneca.comLead Sponsor
AstraZeneca
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions